Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Tables)

v3.23.2
Revenue Recognition (Tables)
 6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Contract Assets and Liabilities The following table summarizes the values of contract assets, capitalized commissions and contract liabilities (in thousands):
June 30, 2023 December 31, 2022
Current contract assets (1)
$ 810  $ 1,898 
Long-term contract assets (2)
—  31 
Total assets $ 810  $ 1,929 
Current capitalized commissions (1)
$ 923  $ 800 
Long-term capitalized commissions (2)
437  715 
Total capitalized commissions $ 1,360  $ 1,515 
Current contract liabilities $ 5,712  $ 7,557 
Long-term contract liabilities (3)
—  19 
Total contract liabilities $ 5,712  $ 7,576 

(1) Recorded within other current assets on the Consolidated Balance Sheets.
(2) Recorded within other assets on the Consolidated Balance Sheets.
(3) Recorded within other long-term liabilities on the Consolidated Balance Sheets.
Schedule of Disaggregation of Revenue
The following table details the disaggregation of revenue for both the Clinical Services and Advanced Diagnostics Segments (in thousands):
Three Months Ended June 30, Six Months Ended June 30,
2023 2022 2023 2022
Clinical Services
    Client direct billing $ 83,176  $ 69,874  $ 159,999  $ 134,888 
    Commercial Insurance 21,695  18,512  43,050  36,800 
    Medicare and Medicaid 18,196  17,167  34,783  32,632 
    Self-Pay 89  82  193  106 
Total Clinical Services $ 123,156  $ 105,635  $ 238,025  $ 204,426 
Advanced Diagnostics 23,761  19,437  46,112  37,815 
Total Revenue $ 146,917  $ 125,072  $ 284,137  $ 242,241